SO
KROS icon

STRS Ohio’s Keros Therapeutics KROS Stock Holding History

STRS Ohio’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$559K Buy
50,600
+21,300
+73% +$329K ﹤0.01% 1020
2025
Q4 		$597K Buy
29,300
+1,100
+4% +$19.3K ﹤0.01% 939
2025
Q3 		$446K Buy
28,200
+18,800
+200% +$278K ﹤0.01% 1156
2025
Q2 		$125K Buy
+9,400
New +$127K ﹤0.01% 1799
2023
Q3 		– Sell
-5,700
Closed -$229K – 2003
2023
Q2 		$229K Buy
5,700
+400
+8% +$17.5K ﹤0.01% 1562
2023
Q1 		$226K Hold
5,300
– – ﹤0.01% 1575
2022
Q4 		$254K Hold
5,300
– – ﹤0.01% 1533
2022
Q3 		$199K Buy
+5,300
New +$184K ﹤0.01% 1606
2021
Q3 		– Sell
-2,000
Closed -$84K – 2283
2021
Q2 		$84K Buy
2,000
+200
+11% +$10.8K ﹤0.01% 2012
2021
Q1 		$110K Hold
1,800
– – ﹤0.01% 1924
2020
Q4 		$126K Hold
1,800
– – ﹤0.01% 1845
2020
Q3 		$69K Hold
1,800
– – ﹤0.01% 1913
2020
Q2 		$67K Buy
+1,800
New +$55.5K ﹤0.01% 1861

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return